News

Video

WIO 2023: ICL and Clear Lens Exchange

Author(s):

Eva Kim, MD, spoke with our team to share insights from her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.

Eva Kim, MD, spoke with our team to share insights from her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.

Video Transcript

Editor's note - This transcript has been edited for clarity.

David Hutton:

I'm David Hutton of Ophthalmology Times. Joining me today is Dr. Eva Kim who will present ICL and Clear Lens Exchange at the Women in Ophthalmology 2023 Summer Symposium. Thank you so much for joining us today. Tell us a little bit about your presentation.

Eva Kim, MD:

Thanks, David. I'm excited to be presenting on CLE versus ICL surgery. CLE standing for clear lens exchange or refractive lens exchange. I'm going to talk about the fact that they're both lens based refractive surgeries. I'm going to talk about how these are non-corneal refractive surgeries and perfect surgeries for anterior segment surgeons, especially anterior segment surgeons who are excited to become more involved with refractive surgery. But they perhaps get a little bit nervous about entering corneal refractive surgery. And so just presenting how these are perfect, almost gateway surgeries for refractive surgery for anterior segment surgeons. I'll talk about the difference in patient profiles, the advantages and disadvantages to the surgeries. So really excited to share this information with everyone.

David Hutton:

What makes this a special event?

Eva Kim, MD:

I am very excited to be attending WIO because it's actually my first WIO that I'm officially attending ever in my entire life. So I'm excited to not only be a speaker, but to be an attendee for the first time. It's a special event, I am assuming, because of the support and the empowerment that we'll be feeling as women physicians, and I am excited to see a lot of colleagues that I have known throughout my career and just to feel that support.

David Hutton:

Are there any topics that you're particularly interested in during this event?

Eva Kim, MD:

I'm very excited to learn a little bit more about some of the MIGs related, or to hear some of the MIGs related talks from my colleagues. And also I am a uveitis specialist, but have been a little more active in cataract and refractive over the past five years so I'd love to hear those updates as well.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.